Skip to main content

CVS Health Corp

corporate_fare Company Profile

CVS Health Corp

CVS·NYSE·Trade & Services·CIK 0000064803

CVS Health Corporation is a leading health solutions company that connects care for consumers. As of December 31, 2025, the company operated approximately 9,000 retail locations and over 1,000 walk-in and primary care medical clinics. It also manages a pharmacy benefits manager serving approximately 87 million plan members, alongside expanding specialty pharmacy solutions. CVS Health provides traditional, voluntary, and consumer-directed health insurance products and related services to an estimated more than 37 million people. This includes growing Medicare Advantage offerings and a prominent standalone Medicare Part D prescription drug plan. The company aims to expand into personalized, technology-driven care delivery and health services. CVS Health operates through four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. The Health Care Benefits segment, operating through its Aetna® operations, is one of the nation's leading diversified health care benefits providers, serving an estimated more than 37 million people as of December 31, 2025.

CVS Health Corp (NYSE:CVS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 44 items for CVS at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • CVS Health Commits $2.1B to Affordable Housing, Expands Google Cloud Partnership
  • CVS Health Forges Strategic Partnership with Google Cloud to Transform Healthcare Engagement
  • CVS Health Reports Steep Profit Decline Driven by $5.7B Goodwill Impairment and $1.5B Litigation Charges in 2025 Annual Report
  • CVS Health Reports Mixed Q4 & Full-Year 2025 Results, Lowers 2026 Cash Flow Guidance Amid Significant Charges

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$402.07B
Net Income
$1.77B
Diluted EPS
$1.39
Op. Cash Flow
$10.64B
Free Cash Flow
$7.81B
Gross Profit
$180.9B
Operating Income
$4.66B
Cash & Equivalents
$8.45B
Total Debt
$0
Debt / Equity
0.00×
Net Margin
0.4%
Shares Outstanding
1.27B sh
Source: 10-K · filed 2026-02-10 · accession 0000064803-26-000010
$79.92 -1.14% today
52-week range · as of 2026-11-04 $69.51 – $110.68
Market cap
$103.43B
Volume
10.7M (0.9× avg)
3-mo avg 11.4M
Live data · 2026-11-22 12:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CVS - Filings & News (Page 3)

CVS
Mar 06, 2026, 3:03 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $78.34
Real-time Price: $79.92 info
Change: +$1.58 (+2%) info
Market Cap: $103.433B info
CVS
Mar 05, 2026, 9:01 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $80.00
Real-time Price: $79.92 info
Change: -$0.080 (-0.10%) info
Market Cap: $103.433B info
CVS
Feb 10, 2026, 6:36 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $73.75
Real-time Price: $79.92 info
Change: +$6.17 (+8%) info
Market Cap: $103.433B info
CVS
Feb 10, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $76.09
Real-time Price: $79.92 info
Change: +$3.83 (+5%) info
Market Cap: $103.433B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets